Literature DB >> 18641360

The epithelial anion transporter pendrin is induced by allergy and rhinovirus infection, regulates airway surface liquid, and increases airway reactivity and inflammation in an asthma model.

Yasuhiro Nakagami1, Silvio Favoreto, Guohua Zhen, Sung-Woo Park, Louis T Nguyenvu, Douglas A Kuperman, Gregory M Dolganov, Xiaozhu Huang, Homer A Boushey, Pedro C Avila, David J Erle.   

Abstract

Asthma exacerbations can be triggered by viral infections or allergens. The Th2 cytokines IL-13 and IL-4 are produced during allergic responses and cause increases in airway epithelial cell mucus and electrolyte and water secretion into the airway surface liquid (ASL). Since ASL dehydration can cause airway inflammation and obstruction, ion transporters could play a role in pathogenesis of asthma exacerbations. We previously reported that expression of the epithelial cell anion transporter pendrin is markedly increased in response to IL-13. Herein we show that pendrin plays a role in allergic airway disease and in regulation of ASL thickness. Pendrin-deficient mice had less allergen-induced airway hyperreactivity and inflammation than did control mice, although other aspects of the Th2 response were preserved. In cultures of IL-13-stimulated mouse tracheal epithelial cells, pendrin deficiency caused an increase in ASL thickness, suggesting that reductions in allergen-induced hyperreactivity and inflammation in pendrin-deficient mice result from improved ASL hydration. To determine whether pendrin might also play a role in virus-induced exacerbations of asthma, we measured pendrin mRNA expression in human subjects with naturally occurring common colds caused by rhinovirus and found a 4.9-fold increase in mean expression during colds. Studies of cultured human bronchial epithelial cells indicated that this increase could be explained by the combined effects of rhinovirus and IFN-gamma, a Th1 cytokine induced during virus infection. We conclude that pendrin regulates ASL thickness and may be an important contributor to asthma exacerbations induced by viral infections or allergens.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641360      PMCID: PMC2491716          DOI: 10.4049/jimmunol.181.3.2203

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  56 in total

1.  ADAM33 is not essential for growth and development and does not modulate allergic asthma in mice.

Authors:  Chun Chen; Xiaozhu Huang; Dean Sheppard
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

2.  Study of modifiable risk factors for asthma exacerbations: virus infection and allergen exposure increase the risk of asthma hospital admissions in children.

Authors:  C S Murray; G Poletti; T Kebadze; J Morris; A Woodcock; S L Johnston; A Custovic
Journal:  Thorax       Date:  2005-12-29       Impact factor: 9.139

3.  The asthma channel? Stay tuned . . .

Authors:  David J Erle; Guohua Zhen
Journal:  Am J Respir Crit Care Med       Date:  2006-06-01       Impact factor: 21.405

Review 4.  Airway surface dehydration in cystic fibrosis: pathogenesis and therapy.

Authors:  Richard C Boucher
Journal:  Annu Rev Med       Date:  2007       Impact factor: 13.739

5.  Design, synthesis, and structure-activity relationships of novel 2-substituted pyrazinoylguanidine epithelial sodium channel blockers: drugs for cystic fibrosis and chronic bronchitis.

Authors:  Andrew J Hirsh; Bruce F Molino; Jianzhong Zhang; Nadezhda Astakhova; William B Geiss; Bruce J Sargent; Brian D Swenson; Alexander Usyatinsky; Michael J Wyle; Richard C Boucher; Rick T Smith; Andra Zamurs; M Ross Johnson
Journal:  J Med Chem       Date:  2006-07-13       Impact factor: 7.446

6.  Genetic segregation of airway disease traits despite redundancy of calcium-activated chloride channel family members.

Authors:  Anand C Patel; Jeffrey D Morton; Edy Y Kim; Yael Alevy; Suzanne Swanson; Jennifer Tucker; Guaming Huang; Eugene Agapov; Thomas E Phillips; Maria E Fuentes; Antonio Iglesias; Dee Aud; John D Allard; Karim Dabbagh; Gary Peltz; Michael J Holtzman
Journal:  Physiol Genomics       Date:  2006-03-28       Impact factor: 3.107

7.  IL-13 and epidermal growth factor receptor have critical but distinct roles in epithelial cell mucin production.

Authors:  Guohua Zhen; Sung Woo Park; Louis T Nguyenvu; Madeleine W Rodriguez; Rebecca Barbeau; Agnes C Paquet; David J Erle
Journal:  Am J Respir Cell Mol Biol       Date:  2006-09-15       Impact factor: 6.914

8.  Niflumic acid suppresses interleukin-13-induced asthma phenotypes.

Authors:  Takako Nakano; Hiromasa Inoue; Satoru Fukuyama; Koichiro Matsumoto; Mikiko Matsumura; Miyuki Tsuda; Takafumi Matsumoto; Hisamichi Aizawa; Yoichi Nakanishi
Journal:  Am J Respir Crit Care Med       Date:  2006-03-09       Impact factor: 21.405

9.  Thiocyanate transport in resting and IL-4-stimulated human bronchial epithelial cells: role of pendrin and anion channels.

Authors:  Nicoletta Pedemonte; Emanuela Caci; Elvira Sondo; Antonella Caputo; Kerry Rhoden; Ulrich Pfeffer; Michele Di Candia; Roberto Bandettini; Roberto Ravazzolo; Olga Zegarra-Moran; Luis J V Galietta
Journal:  J Immunol       Date:  2007-04-15       Impact factor: 5.422

Review 10.  How viral infections cause exacerbation of airway diseases.

Authors:  Patrick Mallia; Sebastian L Johnston
Journal:  Chest       Date:  2006-10       Impact factor: 9.410

View more
  44 in total

1.  Epithelial anion transporter pendrin contributes to inflammatory lung pathology in mouse models of Bordetella pertussis infection.

Authors:  Karen M Scanlon; Yael Gau; Jingsong Zhu; Ciaran Skerry; Susan M Wall; Manoocher Soleimani; Nicholas H Carbonetti
Journal:  Infect Immun       Date:  2014-07-28       Impact factor: 3.441

Review 2.  Oxidative stress, autophagy and airway ion transport.

Authors:  Scott M O'Grady
Journal:  Am J Physiol Cell Physiol       Date:  2018-10-10       Impact factor: 4.249

3.  Neuropeptide regulation of secretion and inflammation in human airway gland serous cells.

Authors:  Derek B McMahon; Ryan M Carey; Michael A Kohanski; Charles C L Tong; Peter Papagiannopoulos; Nithin D Adappa; James N Palmer; Robert J Lee
Journal:  Eur Respir J       Date:  2020-04-16       Impact factor: 16.671

4.  Analysis of Lung Gene Expression Reveals a Role for Cl- Channels in Diisocyanate-induced Airway Eosinophilia in a Mouse Model of Asthma Pathology.

Authors:  Adam V Wisnewski; Jian Liu; Carrie A Redlich
Journal:  Am J Respir Cell Mol Biol       Date:  2020-07       Impact factor: 6.914

Review 5.  Novel therapies for the treatment of pertussis disease.

Authors:  Karen M Scanlon; Ciaran Skerry; Nicholas H Carbonetti
Journal:  Pathog Dis       Date:  2015-09-21       Impact factor: 3.166

Review 6.  Exosomes in immunoregulation of chronic lung diseases.

Authors:  K P Hough; D Chanda; S R Duncan; V J Thannickal; J S Deshane
Journal:  Allergy       Date:  2016-12-08       Impact factor: 13.146

Review 7.  Barriers to inhaled gene therapy of obstructive lung diseases: A review.

Authors:  Namho Kim; Gregg A Duncan; Justin Hanes; Jung Soo Suk
Journal:  J Control Release       Date:  2016-05-16       Impact factor: 9.776

8.  Do mutations of the Pendred syndrome gene, SLC26A4, confer resistance to asthma and hypertension?

Authors:  A C Madeo; A Manichaikul; S P Pryor; A J Griffith
Journal:  J Med Genet       Date:  2009-03-15       Impact factor: 6.318

9.  Distinct roles of FOXA2 and FOXA3 in allergic airway disease and asthma.

Authors:  Sung-Woo Park; Catherine Verhaeghe; Louis T Nguyenvu; Rebecca Barbeau; Christopher J Eisley; Yasuhiro Nakagami; Xiaozhu Huang; Prescott G Woodruff; John V Fahy; David J Erle
Journal:  Am J Respir Crit Care Med       Date:  2009-07-23       Impact factor: 21.405

10.  Thiocyanate: a potentially useful therapeutic agent with host defense and antioxidant properties.

Authors:  Joshua D Chandler; Brian J Day
Journal:  Biochem Pharmacol       Date:  2012-08-08       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.